HOME › DRUGS › LIRAGLUTIDE
ACTIVE SUBSTANCE / INN

LIRAGLUTIDE

Brand name(s): Victoza, VICTOZA, Saxenda, SAXENDA, LIRAGLUTIDE, XULTOPHY 100/3.6
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA206321
Obesity;Overweight
ACTIVE SUBSTANCE
Liraglutide
REGULATORS
FDA · EMA
SPONSORS / MAH
Novo Nordisk A/S, NOVO, ORBICULAR
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LIRAGLUTIDEANDA217234ORBICULARPrescription
XULTOPHY 100/3.6BLA208583NOVOPrescription
VICTOZANDA022341NOVO NORDISK INCPrescription
SAXENDANDA206321NOVOPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VictozaNovo Nordisk A/SAuthorised30/06/2009Diabetes Mellitus, Type 2
SaxendaNovo Nordisk A/SAuthorised23/03/2015Obesity;Overweight

FULL INTELLIGENCE ON LIRAGLUTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →